Tender Title | (ph No. : 25098) Bevacizumab 100 Mg Inj,unit:vial | ||
Tender ID | NA | Tender Reference Number | SCRLGD252509610270R2 |
Tender Type | Limited | ||
Tender Opening Date | 2025-08-24 04:46 PM | Tender Closing Date | 2025-08-30 05:00 AM |
Tender Value | Refer Document | Tender Location | Secunderabad , Hyderabad , Telangana |
Tender Category | Goods | Product Category | Healthcare and Medicine Tenders |
ePublished Date | 2025-08-24 04:46 PM | Bid Opening Date | 2025-08-30 05:00 AM |
Document Download Start Date | 2025-08-24 04:46 PM | Document Download End Date | 2025-08-30 05:00 AM |
Bid Submission Start Date | 2025-08-24 04:46 PM | Bid Submission End Date | 2025-08-30 05:00 AM |
Clarification start Date | Clarification End Date | ||
Bid Validity Period (in Days) | NA |
Tender Fee | Refer document |
EMD (Earnest Money Deposit) | Refer document |
EMD Fee Type | NA |
Payment Instruments/Mode | NA |
Work Description - For Complete Deion And Other Details, Please Refer To Tender
The Ministry of Railways, a Central Government entity, invites tenders for the supply of goods, specifically, BEVACIZUMAB 100 MG INJ (PH NO. : 25098), UNIT: VIAL, categorized as Railway related Products. This is a Limited Tender, reference number SCRLGD252509610270R2, with no tender fee or EMD required. Interested parties can download tender documents starting from 24-Aug-2025 10:16 PM and must submit their bids between 24-Aug-2025 10:16 PM and 30-Aug-2025 10:30 AM. The bid opening date is 30-Aug-2025 10:30 AM. Further details and complete descriptions can be found within the tender documents. The Tender Inviting Authority is MEDICAL/SOUTH CENTRAL RLY, located at CENTRAL HOSPITAL LALLAGUDA, Secunderabad.
Get Hassle free financing for your business
Office Inviting Bids | Medical/south Central Rly |
Address | Central Hospital Lallaguda Secunderabad |
Contact Details | NA |
NA | |
Website | NA |
(ph No.:25026) Cyclophosphamide 500 Mg Inj,unit:vial..read more
(ph No.:25005) Doxorubicin Hcl 50 Mg Inj,unit:vial..read more
(ph No.:70091) Inj. Tocilizumab 80mg,unit:vial..read more
(ph No.:26012) Spironolactone 100 Mg Tab..read more
(ph No.17050) Evolocumab Solution For Injection 140mg/ml,unit:vial..read more
All the major brands in each raw material category